Clinical Trials Logo

Heart Arrest, Out-Of-Hospital clinical trials

View clinical trials related to Heart Arrest, Out-Of-Hospital.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT03079102 Terminated - Clinical trials for Heart Arrest, Out-Of-Hospital

Inhaled Nitric Oxide After Out-of-Hospital Cardiac Arrest

iNOOHCA
Start date: August 26, 2017
Phase: Phase 2
Study type: Interventional

Phase II double blind (participants and investigator) placebo controlled randomized (1:1) clinical trial of inhaled nitric oxide (iNO) 20 ppm administered over 12h beginning as soon as possible but within 4 h of return of spontaneous circulation (ROSC) from out-of-hospital cardiac arrest (OHCA). Planned enrollment is 180 subjects over 48 months at University of Pittsburgh Medical Center (UPMC) Hospitals with randomization stratified in blocks of 8. Recruitment will be performed under exception from informed consent (EFIC) to facilitate early enrollment and treatment. The study will have a pre-specified safety analysis at the mid-point (after 1 year or 60 patients whichever occurs first). Subjects will be screened by members of the University of Pittsburgh post-cardiac arrest service (PCAS), all of whom will serve as the study co-investigators, and the Research Coordinators. Notification of inclusion under EFIC will be performed as soon as possible by a member of the study team generally to a surrogate as the subjects will be comatose after OHCA.